Physician
Nephrology Medical Group of Bakersfield INC
Nephrology Medical Group of Bakersfield INC was paid $1.37M by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 96365, Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour — 38% of everything it billed.
33Billing provider infoNEPHROLOGY MEDICAL GROUP OF BAKERSFIELD INC
BAKERSFIELD, CA 93308
BAKERSFIELD, CA 93308
33aNPI1457783938assigned 08/06/2013
33bProvider typeNephrology Physician
28Total paid$1.37M
24GClaims30,528
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Nephrology Physician providers in California
Rank by total paid#34 of 363
Median peer was paid$80K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,575 | $304K | |
| 2019 | 4,067 | $175K | |
| 2020 | 3,590 | $219K | |
| 2021 | 3,473 | $209K | |
| 2022 | 3,436 | $173K | |
| 2023 | 4,527 | $158K | |
| 2024incomplete | 2,860 | $137K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 38% | 8,454 | 1,682 | $525K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 5,229 | 4,420 | $296K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 4,675 | 2,860 | $204K |
| 90961 | 3.4% | 339 | 335 | $47K | |
| 99354 | 3.0% | 329 | 315 | $41K | |
| 94799 | 2.6% | 477 | 476 | $36K | |
| 11043 | 2.3% | 268 | 64 | $31K | |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.0% | 729 | 240 | $28K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.9% | 531 | 160 | $26K |
| 90962 | 1.5% | 163 | 163 | $20K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 246 | 246 | $19K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 1.1% | 466 | 432 | $15K |
35 more codes
| 99223 | Prolong inpt eval add15 m | 1.0% | 174 | $14K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 263 | $13K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 118 | $9K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 98 | $9K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 199 | $6K |
| H0049 | Alcohol and/or drug screening | <1% | 323 | $5K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 311 | $4K |
| 94726 | <1% | 56 | $3K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 51 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 85 | $3K |
| 96127 | <1% | 464 | $3K | |
| 99406 | <1% | 193 | $3K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 73 | $3K |
| 82962 | <1% | 1,003 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,217 | $2K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 52 | $2K |
| 94010 | <1% | 56 | $2K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 18 | $933.40 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 51 | $492.22 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 181 | $318.43 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 99 | $300.89 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 19 | $296.86 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 53 | $190.19 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 414 | $138.97 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 26 | $119.16 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 53 | $77.75 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 480 | $71.01 |
| 99318 | <1% | 15 | $16.72 | |
| 1036F | 0% | 518 | $0.00 | |
| 3044F | 0% | 25 | $0.00 | |
| 3074F | 0% | 386 | $0.00 | |
| 3079F | 0% | 31 | $0.00 | |
| 3075F | 0% | 14 | $0.00 | |
| 3078F | 0% | 467 | $0.00 | |
| 3077F | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRAR, HARJEET (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Infusion and Clinical Services, INC | Bakersfield, CA | $29.08M |
| Infusion and Clinical Services, INC. | Bakersfield, CA | $18.47M |
| Kern Rural Wellness Centers, INC. | Arvin, CA | $15.22M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.